Maladies complexes

Description

COVID longue

maladies_complexes_covid_longue via biblio.chum on Inoreader

Identifying and mitigating the public health consequences of meta-ignorance about "Long COVID" risks
on 13 février 2025
Public Health. 2025 Feb 11;241:19-23. doi: 10.1016/j.puhe.2025.02.003. Online ahead of print.ABSTRACTOBJECTIVES: While past work studies public concern about "Long COVID," fewer have asked what the public knows and/or purports to know about Long […]
Association between chronic fatigue syndrome/myalgic encephalomyelitis and cardiovascular disease
on 11 février 2025
Sci Rep. 2025 Jan 17;15(1):2294. doi: 10.1038/s41598-025-86609-4.ABSTRACTChronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is a medical condition characterized by severe and prolonged fatigue that is not relieved by rest or attributed […]
Long covid as a long term condition
on 11 février 2025
BMJ Med. 2025 Jan 31;4(1):e001366. doi: 10.1136/bmjmed-2025-001366. eCollection 2025 Jan.NO ABSTRACTPMID:39906532 | PMC:PMC11792270 | DOI:10.1136/bmjmed-2025-001366
Interventions for the management of post-COVID-19 condition (long COVID): protocol for a living systematic review and network meta-analysis
on 11 février 2025
BMJ Open. 2025 Feb 7;15(2):e086407. doi: 10.1136/bmjopen-2024-086407.ABSTRACTBACKGROUND: Up to 15% of survivors of COVID-19 infection experience long-term health effects, including fatigue, myalgia and impaired cognitive function, termed […]
Energy management education for persons living with long COVID-related fatigue (EMERGE): protocol of a two-parallel arms target trial emulation study in a multicentre outpatient intervention setting with an online control group register
on 11 février 2025
BMJ Open. 2025 Feb 7;15(2):e098574. doi: 10.1136/bmjopen-2024-098574.ABSTRACTINTRODUCTION: Energy management education (EME) is a manualised, evidence-based self-management education programme developed and delivered by occupational therapists for […]
Prevalence and Impact of Post-Exertional Malaise on Recovery in Adults with Post COVID-19 Condition. A Systematic Review with Meta-Analysis
on 11 février 2025
Arch Phys Med Rehabil. 2025 Feb 5:S0003-9993(25)00501-5. doi: 10.1016/j.apmr.2025.01.471. Online ahead of print.ABSTRACTOBJECTIVE: To assess the prevalence of PEM in people with PCC; and the change in prevalence of PEM following rehabilitation […]
Classifying COVID-19 hospitalizations in epidemiology cohort studies: The C4R study
on 11 février 2025
PLoS One. 2025 Feb 10;20(2):e0316198. doi: 10.1371/journal.pone.0316198. eCollection 2025.ABSTRACTRATIONALE: Robust COVID-19 outcomes classification is important for ongoing epidemiology research on acute and post-acute COVID-19 conditions. […]
Long COVID Prevalence and Associated Activity Limitation in US Children
on 11 février 2025
JAMA Pediatr. 2025 Feb 3. doi: 10.1001/jamapediatrics.2024.6206. Online ahead of print.NO ABSTRACTPMID:39899316 | DOI:10.1001/jamapediatrics.2024.6206
Post-SARS-CoV-2 Onset Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symptoms in Two Cohort Studies of COVID-19 Recovery
on 11 février 2025
medRxiv [Preprint]. 2024 Nov 8:2024.11.08.24316976. doi: 10.1101/2024.11.08.24316976.ABSTRACTOBJECTIVE: To determine how many people with long COVID also meet diagnostic criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome […]
Exploring the experiences of cognitive symptoms in Long COVID: a mixed-methods study in the UK
on 11 février 2025
BMJ Open. 2025 Jan 25;15(1):e084999. doi: 10.1136/bmjopen-2024-084999.ABSTRACTOBJECTIVE: To explore the lived experiences and extent of cognitive symptoms in Long COVID (LC) in a UK-based sample.DESIGN: This study implemented a mixed-methods design. […]
Potential Biomarkers for Predicting the Risk of Developing Into Long COVID After COVID-19 Infection
on 11 février 2025
Immun Inflamm Dis. 2025 Jan;13(1):e70137. doi: 10.1002/iid3.70137.ABSTRACTBACKGROUND: Long COVID, a heterogeneous condition characterized by a range of physical and neuropsychiatric presentations, can be presented with a proportion of […]
Sex Differences in Long COVID
on 11 février 2025
JAMA Netw Open. 2025 Jan 2;8(1):e2455430. doi: 10.1001/jamanetworkopen.2024.55430.ABSTRACTIMPORTANCE: A substantial number of individuals worldwide experience long COVID, or post-COVID condition. Other postviral and autoimmune conditions have a […]
Predicting work ability impairment in post COVID-19 patients: a machine learning model based on clinical parameters
on 11 février 2025
Infection. 2025 Jan 16. doi: 10.1007/s15010-024-02459-8. Online ahead of print.ABSTRACTThe Post COVID-19 condition (PCC) is a complex disease affecting health and everyday functioning. This is well reflected by a patient's inability to work (ITW). […]
Choroid plexus volume is enlarged in long COVID and associated with cognitive and brain changes
on 11 février 2025
Mol Psychiatry. 2025 Jan 15. doi: 10.1038/s41380-024-02886-x. Online ahead of print.ABSTRACTPatients with post-COVID condition (PCC) present with diverse symptoms which persist at long-term after SARS-CoV-2 infection. Among these symptoms, cognitive […]
Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
on 11 février 2025
Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series Article Open access Published: 06 January 2025 Alison K. Cohen orcid.org/0000-0001-9848-934X1, Toni Wall Jaudon2, Eric M. Schurman […]
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection - Nature.com
on 11 février 2025
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection Nature.com
Post-Acute Sequelae of SARS-CoV-2 Infections: Exercise Limitation and Rehabilitation
on 15 janvier 2025
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice […]
Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health
on 15 janvier 2025
Geroscience. 2025 Jan 7. doi: 10.1007/s11357-024-01487-4. Online ahead of print.ABSTRACTLong COVID (also known as post-acute sequelae of SARS-CoV-2 infection [PASC] or post-COVID syndrome) is characterized by persistent symptoms that extend beyond […]
Factors associated with quality of life in long-COVID syndrome
on 15 janvier 2025
Int J Rehabil Res. 2025 Jan 9. doi: 10.1097/MRR.0000000000000654. Online ahead of print.ABSTRACTApproximately 10% of patients experience persistent symptoms following COVID-19, known as long-COVID syndrome. This cross-sectional study explored […]
Patient-reported outcome measures for post-COVID-19 condition: a systematic review of instruments and measurement properties
on 15 janvier 2025
BMJ Open. 2024 Dec 20;14(12):e084202. doi: 10.1136/bmjopen-2024-084202.ABSTRACTOBJECTIVES: Post-COVID-19 condition (PCC), also referred to as Long COVID, has become an emerging public health issue requiring adequate prevention, treatment and […]

Maladie de Lyme

maladies_complexes_lyme via biblio.chum on Inoreader

Dose Evaluation and Optimization of Amoxicillin in Children Treated for Lyme Disease
on 13 février 2025
J Clin Pharmacol. 2025 Jan 27. doi: 10.1002/jcph.6190. Online ahead of print.ABSTRACTAmoxicillin is commonly used to treat erythema migrans in the first stage of Lyme disease in children, with a recommended dose of 50 mg/kg/day, administered three […]
Lyme disease associated neurological and musculoskeletal symptoms: A systematic review and meta-analysis
on 13 février 2025
Brain Behav Immun Health. 2025 Jan 2;43:100931. doi: 10.1016/j.bbih.2024.100931. eCollection 2025 Feb.ABSTRACTBACKGROUND AND OBJECTIVE: Lyme disease, caused by Borrelia burgdorferi, presents major health challenges worldwide, leading to serious […]
Lyme neuroborreliosis in Japan: Borrelia burgdorferi sensu lato as a cause of meningitis of previously undetermined etiology in hospitalized patients outside of the island of Hokkaido, 2010-2021
on 15 janvier 2025
Eur J Neurol. 2025 Jan;32(1):e70005. doi: 10.1111/ene.70005.ABSTRACTBACKGROUND AND PURPOSE: Clinical manifestations of Lyme borreliosis (LB), caused by Borrelia burgdorferi sensu lato (Bbsl), include erythema migrans, Lyme neuroborreliosis (LNB), […]
Perspective: Incidence of Clinician-Diagnosed Lyme Disease in Manitoba, Canada 2009-2018
on 15 janvier 2025
Vector Borne Zoonotic Dis. 2025 Jan 6. doi: 10.1089/vbz.2024.0088. Online ahead of print.ABSTRACTIntroduction: Lyme disease (LD) surveillance yields useful information to monitor the disease trends and spatial distribution. However, due to several […]
Clinical characteristics and serological profiles of Lyme disease in children: a 15-year retrospective cohort study in Switzerland
on 15 janvier 2025
Lancet Reg Health Eur. 2024 Dec 9;48:101143. doi: 10.1016/j.lanepe.2024.101143. eCollection 2025 Jan.ABSTRACTBACKGROUND: Lyme disease (LD) is caused by Borrelia burgdorferi and is the most common tickborne disease in the northern hemisphere. […]
The Current and Future State of Vaccines for Lyme Disease
on 15 janvier 2025
Clin Infect Dis. 2024 Dec 23:ciae639. doi: 10.1093/cid/ciae639. Online ahead of print.ABSTRACTLyme disease is caused by Borrelia species that are transmitted by Ixodes ticks prevalent in parts of the United States and Europe. A Lyme vaccine […]
bb0689 contributes to the virulence of Borrelia burgdorferi in a murine model of Lyme disease
on 20 Décembre 2024
Infect Immun. 2024 Dec 16:e0045924. doi: 10.1128/iai.00459-24. Online ahead of print.ABSTRACTBorrelia burgdorferi, the Lyme disease pathogen, continuously changes its gene expression profile in order to adapt to ticks and mammalian hosts. The […]
Broadly conserved FlgV controls flagellar assembly and Borrelia burgdorferi dissemination in mice
on 20 Décembre 2024
Nat Commun. 2024 Nov 29;15(1):10417. doi: 10.1038/s41467-024-54806-w.ABSTRACTFlagella propel pathogens through their environments, yet are expensive to synthesize and are immunogenic. Thus, complex hierarchical regulatory networks control flagellar […]
Anti-RA33 Antibodies Are Present in Patients With Lyme Disease
on 20 Décembre 2024
J Clin Rheumatol. 2024 Nov 22. doi: 10.1097/RHU.0000000000002176. Online ahead of print.ABSTRACTBACKGROUND/OBJECTIVE: To determine if anti-RA33 antibodies, which can be seen in early forms of inflammatory arthritis, are present in patients with Lyme […]
Historical Summary of Tick and Animal Surveillance Studies for Lyme Disease in Canada, 1975-2023: A Scoping Review
on 20 Décembre 2024
Zoonoses Public Health. 2024 Nov 22. doi: 10.1111/zph.13191. Online ahead of print.ABSTRACTINTRODUCTION: Lyme disease (LD) is caused by infection with the bacteria Borrelia burgdorferi sensu lato (Bb) through the bite of an infected Ixodes spp. […]
Upcoming Events - Lyme Care Resource Center
on 15 novembre 2024
Invalidation, gender, and the medical encounter in Lyme disease Tuesday, November 19th, 2024, 7:00- 8:30pm EST Alison Rebman, MPH earned her graduate degree from Columbia University in Sociomedical Sciences. She is currently an […]
Identifying the geographic leading edge of Lyme disease in the United States with internet searches: A spatiotemporal analysis of Google Health Trends data
on 15 novembre 2024
PLoS One. 2024 Nov 13;19(11):e0312277. doi: 10.1371/journal.pone.0312277. eCollection 2024.ABSTRACTBACKGROUND: The geographic footprint of Lyme disease is expanding in the United States, which calls for novel methods to identify emerging endemic […]
Lyme disease health-related quality of life and resilience: A gender comparative study.
on 6 novembre 2024
Author Names: Bancsi, Dawn Denisesinicki Database Source: APA PsycInfo <January 2024 Week 1 to October 2024 Week 5> Journal Title: Dissertation Abstracts International Section A: […]
Cardiac Manifestations of Lyme Disease
on 5 novembre 2024
Cardiol Rev. 2024 Oct 24. doi: 10.1097/CRD.0000000000000807. Online ahead of print.ABSTRACTLyme disease (LD) is an inflammatory disorder caused by an infectious bacterial agent and is the most common tick-borne illness in the United States and […]
Initial symptoms and late complication in Lyme neuroborreliosis from the perspective of patients and relatives: a qualitative study
on 5 novembre 2024
BMC Prim Care. 2024 Oct 23;25(1):379. doi: 10.1186/s12875-024-02624-w.ABSTRACTBACKGROUND: Lyme borreliosis is by far the most common vector-borne infection in Western Europe. The most severe manifestation of Lyme borreliosis is Lyme neuroborreliosis […]
Incidence of hospitalizations related to Lyme disease and other tick-borne diseases using Discharge Abstract Database, Canada, 2009-2021
on 5 novembre 2024
PLoS One. 2024 Oct 25;19(10):e0312703. doi: 10.1371/journal.pone.0312703. eCollection 2024.ABSTRACTTo estimate rates of hospitalizations for tick-borne diseases (TBDs) in Canada, retrospective analysis was conducted to determine the incidence of […]
Comparison of 2 Sets of Immunoassays Used in Modified 2-Tiered Testing Algorithms for the Diagnosis of Lyme Disease
on 5 novembre 2024
J Appl Lab Med. 2024 Oct 30:jfae127. doi: 10.1093/jalm/jfae127. Online ahead of print.ABSTRACTBACKGROUND: Since 2019, modified 2-tiered testing (MTTT) algorithms have been available for the diagnosis of Lyme disease. MTTTs replaced the standard […]
Ticks and Lyme disease in natural areas: A segmentation analysis of visitor perceptions of risk and preferred communication strategies.
on 5 novembre 2024
Author Names: Brady, Ryan M,Lemieux, Christopher J,Doherty, Sean T Database Source: APA PsycInfo <January 2024 Week 1 to October 2024 Week 3> Journal Title: Journal of Outdoor […]
Giant Erythema in a Child with Lyme Disease
on 15 octobre 2024
Infect Drug Resist. 2024 Oct 10;17:4343-4348. doi: 10.2147/IDR.S489845. eCollection 2024.ABSTRACTHerein we report a case of Lyme borreliosis in a pediatric patient, highlighting the diagnostic challenges associated with this condition. An […]
Sensorineural hearing loss in Lyme neuroborreliosis
on 15 octobre 2024
Ann Med. 2024 Dec;56(1):2411014. doi: 10.1080/07853890.2024.2411014. Epub 2024 Oct 11.ABSTRACTBACKGROUND: Sensorineural hearing loss (SNHL) has been suggested to occur in patients with Lyme neuroborreliosis (LNB); however, a clear association has […]

Encéphalomyélite myalgique

maladies_complexes_encephalomyelite via biblio.chum on Inoreader

Abnormal T-Cell Activation And Cytotoxic T-Cell Frequency Discriminates Symptom Severity In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
on 11 février 2025
medRxiv [Preprint]. 2025 Jan 6:2025.01.02.24319359. doi: 10.1101/2025.01.02.24319359.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating but poorly-understood disease. ME/CFS symptoms can range from mild to severe, […]
Provocation of brachial plexus and systemic symptoms during the elevated arm stress test in individuals with myalgic encephalomyelitis/chronic fatigue syndrome or idiopathic chronic fatigue
on 11 février 2025
J Transl Med. 2025 Jan 22;23(1):106. doi: 10.1186/s12967-025-06137-7.ABSTRACTBACKGROUND: We have noted that some adolescents and young adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) report difficulty with arms-overhead […]
The search for a blood-based biomarker for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS): from biochemistry to electrophysiology
on 11 février 2025
J Transl Med. 2025 Feb 4;23(1):149. doi: 10.1186/s12967-025-06146-6.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disease of unknown aetiology characterised by symptoms of post-exertional malaise (PEM) and […]
Chronic Fatigue Syndrome: Pulling Back the Curtains
on 11 février 2025
Neuroscientist. 2025 Feb;31(1):5. doi: 10.1177/10738584241308723.NO ABSTRACTPMID:39927439 | DOI:10.1177/10738584241308723
Exercise therapy for chronic fatigue syndrome - PubMed
on 15 janvier 2025
Editorial note: Editorial note (19 December 2024): Larun L, Brurberg KG, Odgaard‐Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD003200. DOI: […]
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study
on 15 janvier 2025
J Gen Intern Med. 2025 Jan 13. doi: 10.1007/s11606-024-09290-9. Online ahead of print.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may occur after infection. How often people develop ME/CFS after SARS-CoV-2 […]
Machine learning and multi-omics in precision medicine for ME/CFS
on 15 janvier 2025
J Transl Med. 2025 Jan 14;23(1):68. doi: 10.1186/s12967-024-05915-z.ABSTRACTMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex and multifaceted disorder that defies simplistic characterisation. Traditional approaches to […]
Efficacy of repeated immunoadsorption in patients with post-COVID myalgic encephalomyelitis/chronic fatigue syndrome and elevated beta2-adrenergic receptor autoantibodies: a prospective cohort study
on 15 janvier 2025
Lancet Reg Health Eur. 2024 Dec 12;49:101161. doi: 10.1016/j.lanepe.2024.101161. eCollection 2025 Feb.ABSTRACTBACKGROUND: Since the pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become the leading trigger for myalgic […]
Re-visiting professional ethics in psychotherapy: reflections on the use of talking therapies as a supportive adjunct for myalgic encephalomyelitis/chronic fatigue syndrome and 'medically unexplained symptoms'
on 15 janvier 2025
J Med Ethics. 2024 Dec 31:jme-2023-109627. doi: 10.1136/jme-2023-109627. Online ahead of print.ABSTRACTFollowing years of debate over the effectiveness of cognitive behavioural therapy for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), […]
Key Pathophysiological Role of Skeletal Muscle Disturbance in Post COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Accumulated Evidence
on 15 janvier 2025
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13669. doi: 10.1002/jcsm.13669.ABSTRACTBACKGROUND: Recent studies provide strong evidence for a key role of skeletal muscle pathophysiology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). […]
A novel frameshift mutation in ADCK1 identified in a case of chronic fatigue syndrome successfully treated with oral 5-ALA/SFC
on 15 janvier 2025
Immunol Med. 2024 Dec 26:1-5. doi: 10.1080/25785826.2024.2445399. Online ahead of print.ABSTRACTChronic Fatigue Syndrome (CFS) is a complex disorder characterized by prolonged, unexplained fatigue and challenging diagnosis. We report the case of a […]
Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study
on 15 janvier 2025
eNeurologicalSci. 2024 Dec 2;38:100537. doi: 10.1016/j.ensci.2024.100537. eCollection 2025 Mar.ABSTRACTBACKGROUND: Myalgic encephalomyelitis (ME) is associated with long COVID and also untoward sequelae after anti-coronavirus vaccination. Recently, […]
The potential of plasma exchange in treating Chronic Fatigue Syndrome and long COVID: Targeting autoimmune and inflammatory mechanisms
on 20 Décembre 2024
Author Names: Akgun Y. Database Source: Embase Daily Updates Journal Title: Transfusion,Transfusion Article Title: The potential of plasma exchange in treating […]
Exercise therapy for chronic fatigue syndrome
on 20 Décembre 2024
Cochrane Database Syst Rev. 2024 Dec 19;12:CD003200. doi: 10.1002/14651858.CD003200.pub9.ABSTRACTBACKGROUND: Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) is a serious disorder characterised by persistent postexertional fatigue […]
Clinical Remission After Therapeutic Apheresis in a Patient Suffering from Long Term Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Case Report
on 20 Décembre 2024
Int Med Case Rep J. 2024 Dec 6;17:997-1002. doi: 10.2147/IMCRJ.S476044. eCollection 2024.ABSTRACTMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating multifactorial illness characterized by profound fatigue persisting for […]
Phase-dependent trends in the prevalence of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) related to long COVID: A criteria-based retrospective study in Japan
on 20 Décembre 2024
PLoS One. 2024 Dec 9;19(12):e0315385. doi: 10.1371/journal.pone.0315385. eCollection 2024.ABSTRACTBACKGROUND: The characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) related to COVID-19 have remained uncertain. To […]
Development and Implementation of an Online Patient Education Program for Children and Adolescents With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Their Parents, Siblings, and School Personnel: Protocol for the Prospective BAYNET FOR ME/CFS Study
on 20 Décembre 2024
JMIR Res Protoc. 2024 Nov 21;13:e54679. doi: 10.2196/54679.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) presents significant challenges for affected children and adolescents, their social environment, and treating […]
Trends and Hotspots in the Health Economics Evaluation of Chronic Fatigue Syndrome
on 15 novembre 2024
Author Names: Wan H.,Wei B.,Qian W.,Zhang J. Database Source: Embase Daily Updates Journal Title: Journal of Multidisciplinary Healthcare,Journal of Multidisciplinary Healthcare […]
Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms
on 15 novembre 2024
J Adv Res. 2024 Nov 8:S2090-1232(24)00530-7. doi: 10.1016/j.jare.2024.11.011. Online ahead of print.ABSTRACTINTRODUCTION: Autoimmune responses contribute to the pathophysiology of Long COVID, affective symptoms and myalgic encephalomyelitis/chronic […]
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities
on 15 novembre 2024
Curr Opin Virol. 2024 Nov 12:101437. doi: 10.1016/j.coviro.2024.101437. Online ahead of print.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease with a complex clinical presentation and an unknown etiology. […]

Syndrome d'Ehlers-Danlos

maladies_complexes_syndrome_ehlers_danlos 2 via biblio.chum on Inoreader

Regulation of Joint Tissues and Joint Function: Is There Potential for Lessons to Be Learned Regarding Regulatory Control from Joint Hypermobility Syndromes?
on 13 février 2025
Int J Mol Sci. 2025 Jan 31;26(3):1256. doi: 10.3390/ijms26031256.ABSTRACTNormal development of joints starts in utero with the establishment of a cellular and extracellular matrix template. Following birth, individual joint tissues grow and mature […]
The Impact of Pain on Everyday Activities of People With Hypermobility Spectrum Disorders or Hypermobility Ehlers Danlos Syndrome
on 13 février 2025
Eur J Pain. 2025 Mar;29(3):e70000. doi: 10.1002/ejp.70000.ABSTRACTBACKGROUND: This study describes aspects of pain and how pain affects everyday life and examines the relation between chronic pain and activity limitations in people with […]
Efficacy of Irbesartan in Celiprolol-Treated Patients With Vascular Ehlers-Danlos Syndrome
on 13 février 2025
Circulation. 2025 Feb 5. doi: 10.1161/CIRCULATIONAHA.124.072849. Online ahead of print.ABSTRACTBACKGROUND: Vascular Ehlers-Danlos syndrome is a rare genetic disorder characterized by defective type III collagen and a high risk of arterial morbidity […]
Pediatrics. Diagnosis of generalized joint hypermobility in children
on 13 février 2025
Rev Med Suisse. 2025 Jan 29;21(903):200-204. doi: 10.53738/REVMED.2025.21.903.200.ABSTRACTJoint hypermobility is a common feature in children and adolescents, often physiological and benign, but it is also a manifestation of hereditary connective […]
The prevalence of hypermobile Ehlers-Danlos syndrome at a gender-affirming primary care clinic
on 13 février 2025
SAGE Open Med. 2025 Jan 22;13:20503121251315021. doi: 10.1177/20503121251315021. eCollection 2025.ABSTRACTOBJECTIVE: This study utilized a sample of trangender, nonbinary, and gender-diverse (TGD) patients to build on emerging literature that […]
Outcomes of Total Joint Arthroplasty in Patients Who Have Ehlers-Danlos Syndrome: A Systematic Review and Meta-Analysis
on 13 février 2025
J Arthroplasty. 2025 Jan 20:S0883-5403(25)00033-6. doi: 10.1016/j.arth.2025.01.018. Online ahead of print.ABSTRACTBACKGROUND: Patients who have Ehlers-Danlos Syndrome (EDS), a group of connective tissue disorders characterized by aberrant collagen […]
Trends in surgical procedures for shoulder instability among patients with Ehlers-Danlos syndrome or joint hypermobility syndrome
on 13 février 2025
JSES Int. 2024 Aug 27;8(6):1164-1168. doi: 10.1016/j.jseint.2024.08.178. eCollection 2024 Nov.ABSTRACTBACKGROUND: Joint hypermobility syndrome (JHS) and Ehlers-Danlos Syndrome (EDS) are connective tissue disorders characterized by increased joint […]
Tenascin-X deficiency causing classical-like Ehlers Danlos syndrome type 1 in humans is a significant risk factor for GI and tracheal ruptures
on 15 janvier 2025
Clin Transl Gastroenterol. 2025 Jan 14. doi: 10.14309/ctg.0000000000000821. Online ahead of print.ABSTRACTBACKGROUND: Classical-like Ehlers Danlos Syndrome type 1 (clEDS1) is a very rare form of Ehlers Danlos Syndrome (EDS) caused by tenascin-X […]
Hypermobile type Ehlers-Danlos syndrome and generalized hypermobile spectrum disorder treatment preferences - a cross-sectional survey of patients
on 15 janvier 2025
Rheumatol Int. 2025 Jan 13;45(1):25. doi: 10.1007/s00296-024-05782-3.ABSTRACTWe aimed to assess the typical experiences, desired outcomes, satisfaction with clinical and anticipated outcomes, and the importance of improvements for individuals with […]
The Financial Impact of Ehlers-Danlos Syndromes on Patients in the United States in 2022
on 15 janvier 2025
Mayo Clin Proc Innov Qual Outcomes. 2024 Dec 14;9(1):100586. doi: 10.1016/j.mayocpiqo.2024.11.003. eCollection 2025 Feb.ABSTRACTOBJECTIVE: To determine the financial impact of Ehlers-Danlos syndromes (EDS) on patients in the United States by […]
Exploring fatigue in Marfan and hypermobile Ehlers-Danlos syndromes: an analytical cross-sectional study in two Italian healthcare centres
on 15 janvier 2025
BMJ Open. 2025 Jan 6;15(1):e087298. doi: 10.1136/bmjopen-2024-087298.ABSTRACTOBJECTIVE: This study investigates the prevalence and underlying factors of fatigue in individuals with Marfan syndrome (MFS) and hypermobile Ehlers-Danlos syndromes […]
Rare vascular complications in classical Ehlers-Danlos syndromes
on 15 janvier 2025
BMJ Case Rep. 2025 Jan 4;18(1):e260109. doi: 10.1136/bcr-2024-260109.ABSTRACTEhlers-Danlos syndromes (EDS) are a group of connective tissue disorders associated with skin, ligament, blood vessel and organ abnormalities. Skin hyperextensibility, […]
Analysis of Antroduodenal Motility in Patients With Hypermobility Spectrum Disorders/Hypermobile Ehlers-Danlos Syndrome
on 15 janvier 2025
Aliment Pharmacol Ther. 2025 Jan 2. doi: 10.1111/apt.18471. Online ahead of print.ABSTRACTHypermobility spectrum disorders (HSD) and hypermobility Ehlers-Danlos syndrome (hEDS) are frequently associated with gastrointestinal symptoms, although the […]
Patient and parent knowledge, understanding, and concerns after a new diagnosis of Ehlers Danlos syndrome
on 15 janvier 2025
Orphanet J Rare Dis. 2024 Dec 30;19(1):493. doi: 10.1186/s13023-024-03517-y.ABSTRACTINTRODUCTION: After diagnosis of Ehlers Danlos Syndrome (EDS), it is unclear what information patients and parents need and understand about EDS. The objective of […]
Vascular Ehlers-Danlos syndrome in children: evaluating the importance of diagnosis and follow-up during childhood
on 15 janvier 2025
Eur J Hum Genet. 2024 Dec 27. doi: 10.1038/s41431-024-01773-x. Online ahead of print.ABSTRACTVascular Ehlers-Danlos syndrome (vEDS) is a rare inherited connective tissue disorder predominantly caused by pathogenic COL3A1 variants. Characteristic […]
Vascular Ehlers-Danlos syndrome, a therapeutic challenge
on 15 janvier 2025
Med Clin (Barc). 2024 Dec 26:S0025-7753(24)00711-5. doi: 10.1016/j.medcli.2024.10.027. Online ahead of print.NO ABSTRACTPMID:39730285 | DOI:10.1016/j.medcli.2024.10.027
Navigating AML treatment in vascular Ehlers-Danlos syndrome: achieving deeper remission with oral azacitidine-a first case report
on 15 janvier 2025
Leuk Lymphoma. 2024 Dec 24:1-5. doi: 10.1080/10428194.2024.2438807. Online ahead of print.NO ABSTRACTPMID:39718456 | DOI:10.1080/10428194.2024.2438807
Comorbidity, misdiagnoses, and the diagnostic odyssey in patients with hypermobile Ehlers-Danlos syndrome
on 20 Décembre 2024
Genet Med Open. 2023 Apr 28;1(1):100812. doi: 10.1016/j.gimo.2023.100812. eCollection 2023.ABSTRACTPURPOSE: The extent of comorbidity and misdiagnosis had been unclear for patients with hypermobile Ehlers-Danlos Syndrome (hEDS), a hereditary […]
Ehlers-Danlos syndromes and related disorders: diagnostic challenges and the need for an interdisciplinary patient care in Germany
on 20 Décembre 2024
Dermatology. 2024 Dec 10:1-23. doi: 10.1159/000542026. Online ahead of print.ABSTRACT(215 words): Introduction: Ehlers-Danlos syndromes (EDS) represent a group of heritable connective tissue disorders characterised by skin hyperelasticity, joint […]
Clinical diagnosis of the monogenic Ehlers-Danlos syndromes
on 20 Décembre 2024
Med Genet. 2024 Dec 3;36(4):225-234. doi: 10.1515/medgen-2024-2060. eCollection 2024 Dec.ABSTRACTMonogenic Ehlers-Danlos syndromes (EDS) are a group of inherited connective tissue conditions that are clinically characterised by joint hypermobility, […]

Études cliniques

maladies_complexes_etudes_cliniques via biblio.chum on Inoreader

Dysbiosis & Long COVID
on 13 février 2025
Conditions: COVID-19 Interventions: Biological: Subjects with and without Long COVID Sponsors: University of Chicago Recruiting
Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients with Long COVID: a Randomized Clinical Trial
on 13 février 2025
Conditions: Long COVID Syndrome Interventions: Other: Education for self-management; Other: Personalised exercise program; Other: Usual Care Sponsors: CEU San Pablo University Not yet recruiting
Research of the Long-COVID-19 Syndrome in the Children
on 11 février 2025
Conditions: Long COVID Interventions: Genetic: Device Sponsors: Samara State Medical University Completed
AT1001 for the Treatment of Long COVID
on 11 février 2025
Conditions: Long COVID; Long COVID-19; Post Acute COVID-19 Syndrome; Post Acute Sequelae of COVID-19 Interventions: Drug: Larazotide Acetate; Drug: Placebo Sponsors: Massachusetts General Hospital Recruiting
Cognitive Rehabilitation for Long COVID
on 11 février 2025
Conditions: Long COVID Interventions: Behavioral: Cognitive Rehabilitation; Other: Education Sponsors: McMaster University; Canadian Institutes of Health Research (CIHR) Completed
Mindfulness-Based Stress Reduction Versus Lifestyle Intervention for Long-Haul Covid-19 Parosmia
on 11 février 2025
Conditions: COVID-19 Interventions: Behavioral: Mindfulness-Based Stress Reduction; Behavioral: Lifestyle Intervention Sponsors: Washington University School of Medicine Terminated
Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial
on 11 février 2025
Conditions: SARS CoV-2 Post-Acute Sequelae Interventions: Drug: Nirmatrelvir/ritonavir; Drug: Remdesivir Sponsors: Mount Sinai Hospital, Canada; Unity Health Toronto; Kingston Health Sciences Centre (Kingston); Niagara Health System Recruiting
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
on 11 février 2025
Conditions: Post COVID-19 Condition; Long COVID Interventions: Drug: Rintatolimod; Other: Placebo / Normal Saline Sponsors: AIM ImmunoTech Inc.; Amarex Clinical Research Completed
REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID
on 11 février 2025
Conditions: Post-COVID-19 Syndrome; Fatigue Syndrome, Chronic Interventions: Other: Anhydrous Enol-Oxaloacetate, a "Medical Food"; Other: White Rice Flour Sponsors: Terra Biological LLC; Bateman Horne Center Completed
Basel Long COVID-19 Cohort Study and Digital Long COVID Substudy
on 11 février 2025
Conditions: Post COVID-19 Condition (PCC) Interventions: Other: Digital intervention (DiLCoS); Other: Data collection Sponsors: University Hospital, Basel, Switzerland; State Secretariat for Education Research and Innovation, Switzerland; European […]
SARS-COV-2 VARIANTS' EFFECT ON PREGNANCY AND LONG-TERM OUTCOMES AMONG PREGNANT WOMEN AND THEIR NEWBORNS IN ESTONIA
on 11 février 2025
Conditions: Pregnancy; COVID-19; Post-COVID / Long-COVID; Newborn Health; Miscarriages Interventions: Other: COVID-19 infection Sponsors: University of Tartu Completed
Long-term Effects of COVID-19
on 11 février 2025
Conditions: COVID-19; SAR-CoV-2 Interventions: Drug: (R)-1-(2-chlorophenyl)- N-[11C] ([11C] PK11195); Drug: 2-(4-[11C]methylamino phenyl)-6-hydroxybenzothiazole (11C]6-OH-BTA-1 or [11C]PIB) Sponsors: Mayo Clinic; National Institute of Neurological […]
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
on 11 février 2025
Conditions: Post-Concussion Syndrome; COVID Long-Haul; COVID-19 Interventions: Device: percutaneous electrical nerve-field stimulation, PENFS; Device: percutaneous electrical nerve-field stimulation, PENFS (sham device); Device: percutaneous […]
Evaluating the Neuromodulatory Effect of Ketamine in Long COVID
on 11 février 2025
Conditions: Long COVID Interventions: Drug: Ketamine only Sponsors: University of Texas at Austin; Roots Behavioral Health Not yet recruiting
Biomarkers for Post-COVID Conditions
on 11 février 2025
Conditions: COVID-19; SARS-CoV-2; Biomarkers; Post-acute COVID-19 Syndrome Sponsors: Zealand University Hospital; Mental Health Services in the Capital Region, Denmark; Skane University Hospital Completed
Persistent COVID-19 Symptoms in Minia
on 11 février 2025
Conditions: COVID - 19 Sponsors: Fayoum University Completed
Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
on 11 février 2025
Conditions: Long COVID; PASC Post Acute Sequelae of COVID 19 Interventions: Drug: Valacyclovir celecoxib dose 1; Drug: Valacyclovir celecoxib dose 2; Drug: Placebo Sponsors: Bateman Horne Center Completed
Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial
on 11 février 2025
Conditions: Post-Acute COVID-19; Post-Acute COVID-19 Syndrome; Post-Acute COVID-19 Infection; Long COVID; Long Covid19; Dyspnea; Orthostasis; Cognitive Impairment Interventions: Other: Comprehensive Rehabilitation; Other: Augmented Usual Care […]
Post-COVID-Health Study: Multidimensional Health Status of COVID-19 Survivors One Year After a SARS-CoV-2 Infection
on 11 février 2025
Conditions: Covid19 Sponsors: Maastricht University Medical Center; VieCuri Medical Centre; Zuyderland Medical Centre Terminated
Understanding the Long-term Impact of COVID on Children and Families
on 11 février 2025
Conditions: SARS-CoV-2 Infection Sponsors: NYU Langone Health; National Heart, Lung, and Blood Institute (NHLBI) Active, not recruiting

Revue d'actualités

maladies_complexes_actualites via biblio.chum on Inoreader

Long COVID impacting more than 1 million children: CDC study suggests
on 11 février 2025
Higher levels of long COVID were found in lower-income households.More than 1 million children may have been affected by long COVID as of 2023, new federal data published Monday suggests.Long COVID, a condition that occurs when patients still have […]
Exeter firm excited over long Covid test breakthrough
on 11 février 2025
Richard GreenBBC News, DevonBBCAttomarker insists the test can help many long Covid patients, should it be rolled out in the future An Exeter-based research firm has developed what it believes is a "world first" breakthrough test to help confirm the […]
En cas de Covid long, 90% des personnes se retrouvent en incapacité de travail totale
on 11 février 2025
Un peu moins de 2% des nouvelles demandes adressées à l'assurance-invalidité (AI) entre 2021 et 2023 concernent des personnes souffrant de Covid long. Cela représente près de 3000 personnes, selon une étude publiée jeudi, la première à […]
Covid long : 2 ans après l'infection, deux tiers des adultes sont encore malades
on 11 février 2025
Le Covid long doit-il à présent être qualifié de maladie chronique à la faible possibilité de guérison ? "Nous le craignons", répond le Pr Winfried Kern, médecin interniste et infectiologue à l'université de Fribourg (Allemagne). Deux […]
Les femmes sont plus à risque de développer un Covid long que les hommes
on 11 février 2025
Par Camille Gaubert le 24.01.2025 à 17h38 Ecouter 3 min. Les femmes ont un risque augmenté de 31% de développer un Covid long par rapport aux hommes, d'après une étude. Une différence qui se creuse encore pour les plus de 40 ans.
Do We Need a Lyme Disease Vaccine?
on 15 janvier 2025
Pediatr Infect Dis J. 2025 Jan 1;44(1):32. doi: 10.1097/INF.0000000000004537. Epub 2024 Oct 7.NO ABSTRACTPMID:39705403 | DOI:10.1097/INF.0000000000004537
Patients With HIV May Have High Prevalence of Long COVID - AJMC.com Managed Markets Network
on 15 janvier 2025
Patients With HIV May Have High Prevalence of Long COVID AJMC.com Managed Markets Network
NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2 - National Institutes of Health
on 15 janvier 2025
NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2 National Institutes of Health
La force du nombre pour affronter la COVID longue - La Tribune
on 15 janvier 2025
La force du nombre pour affronter la COVID longue La Tribune
VIDÉO | Le tiers des tiques sont porteuses de l’anaplasmose transmissible à l’humain - Noovo Info
on 20 Décembre 2024
VIDÉO | Le tiers des tiques sont porteuses de l’anaplasmose transmissible à l’humain Noovo Info
https://healthsci.mcmaster.ca/mcmaster-researchers-find-talk-therapy-rehabilitation-likely-improve-long-covid-symptoms/
on 20 Décembre 2024
When Long COVID Makes You Extra Thirsty > News > Yale Medicine
on 20 Décembre 2024
Among the many symptoms that have been reported by people experiencing Long COVID, one of the more recent is an unusual level of thirst. This could mean that the feeling of thirst may keep getting stronger and last longer than usual. Or that even […]
Notes from the Field: Long COVID and Significant Long... - CDC
on 20 Décembre 2024
Notes from the Field: Long COVID and Significant Long... CDC
La maladie l'invalide depuis 9 mois | COVID longue: «La vie d'avant n'existe plus» - 98.5 Montréal
on 20 Décembre 2024
La maladie l'invalide depuis 9 mois | COVID longue: «La vie d'avant n'existe plus» 98.5 Montréal
Many long COVID patients adjust to slim recovery odds as world moves on - CTV News
on 15 novembre 2024
Many long COVID patients adjust to slim recovery odds as world moves on CTV News
Des symptômes de COVID longue même chez des personnes qui n’ont pas eu la COVID-19 - Le Quotidien
on 15 novembre 2024
Des symptômes de COVID longue même chez des personnes qui n’ont pas eu la COVID-19 Le Quotidien
Difficulté d’accès aux soins pour le personnel soignant atteint de la COVID longue - Le Nouvelliste
on 15 novembre 2024
Difficulté d’accès aux soins pour le personnel soignant atteint de la COVID longue Le Nouvelliste
COVID longue, celle dont on ne veut pas prononcer le nom - Collège des médecins du Québec
on 15 novembre 2024
COVID longue, celle dont on ne veut pas prononcer le nom Collège des médecins du Québec
Le carnet de santé : le brouillard de la COVID longue - L’actualité
on 15 novembre 2024
Le carnet de santé : le brouillard de la COVID longue L’actualité
Le risque de COVID longue augmente après plusieurs infections - Radio-Canada.ca
on 6 novembre 2024
Le risque de COVID longue augmente après plusieurs infections Radio-Canada.ca

Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.

Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.

Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.

Avis de non-responsabilité

1. EXCLUSION DE GARANTIES ET LIMITATION DE RESPONSABILITÉ

Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit.

Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.

2. RESPONSABILITÉ RELATIVES AUX LIENS

Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées.

Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.

3. PROPRIÉTÉ INTELLECTUELLE

Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42).

Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité.

Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables.